High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 5, 2002, Pages 1111-1116

  Zelefsky, Michael J ^a   Fuks, Zvi ^a   Hunt, Margie ^a   Yamada, Yoshiya ^a   Marion, Christine ^a   Ling, C Clifton ^a   Amols, Howard ^a   Venkatraman, E S ^a   Leibel, Steven A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Intensity modulation; Prostate cancer; Radiotherapy; Toxicity

Indexed keywords

PATIENT TREATMENT; TOXICITY; TUMORS;

COLLIMATION; FEASIBILITY;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CAUTERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RECTUM HEMORRHAGE; SURVIVAL RATE; TRANSFUSION; URETHRA STRICTURE; URINE RETENTION;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036680294     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02857-2     Document Type: Article

References (25)

1. Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer
2. Dose selection for prostate cancer based on dose comparison and dose response studies
3. Preliminary results of a randomized radiotherapy dose escalation study comparing 70 Gy to 78 Gy for prostate cancer
4. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate
5. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
6. Long term tolerance of high dose three dimensional conformal radiotherapy in patients with localized prostate cancer
7. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms
8. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial
9. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer
10. Locally advanced prostatic cancer: Long-term toxicity after three-dimensional conformal radiation therapy - A dose-escalation study
11. Prostate
12. Histologic grading and clinical staging of prostatic carcinoma
13. Conformal radiation treatment of prostate cancer using inversely planned intensity-modulated photon beams produced with dynamic multileaf collimation
14. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate
15. X-ray field compensators with multi-leaf collimators
16. The potential and limitations of the inverse radiotherapy technique
17. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy
18. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
19. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706
20. Consensus statement: Guidelines for PSA following radiation therapy
21. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis
22. Nonparametric estimation from incomplete observations
23. Evaluation of survival data and two rank order statistics arising in its consideration
24. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer
25. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction